JAMA Cardiology

Papers
(The H4-Index of JAMA Cardiology is 71. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China2887
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)2794
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)1534
Potential Effects of Coronaviruses on the Cardiovascular System1299
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)1267
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases605
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes598
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)492
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality417
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China400
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military388
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)299
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia253
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination229
Sex Differences in Blood Pressure Trajectories Over the Life Course226
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection223
Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease 2019 Pandemic in New York City207
Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening192
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Car187
Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection183
A Game Plan for the Resumption of Sport and Exercise After Coronavirus Disease 2019 (COVID-19) Infection161
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers160
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease155
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi154
Coronavirus Disease 2019 and the Athletic Heart153
Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic Use152
Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging148
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease140
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019139
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children133
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019132
Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors122
Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure—Optimizing Therapy With the Need for Speed122
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab120
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia118
Evolving Trends in Adult Heart Transplant With the 2018 Heart Allocation Policy Change118
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction118
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents113
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome112
Use of Machine Learning Models to Predict Death After Acute Myocardial Infarction111
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction110
Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic106
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve104
Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent104
Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis103
Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic101
Screening for Atrial Fibrillation in the Older Population99
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia97
Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure96
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 201796
Development of Persistent Opioid Use After Cardiac Surgery93
Association of Adverse Childhood Experiences With Cardiovascular Disease Later in Life93
Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction93
Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes91
Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting90
Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure86
Mechanical Complications of Acute Myocardial Infarction86
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US84
Association of High-Density Calcified 1K Plaque With Risk of Acute Coronary Syndrome84
Lipoprotein(a) and its Significance in Cardiovascular Disease82
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis82
Volume-Outcome Association of Mitral Valve Surgery in the United States81
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines79
Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women79
New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation79
Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults74
Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart Failure74
Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials73
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction73
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes72
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial71
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases71
Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction71
0.050780057907104